Naleya Genomik Indonesia

Who We Are

Naleya Genomik Indonesia, a joint venture with BGI Genomics, stands as a beacon for health advancement in Indonesia. Committed to “Omics for Indonesia”, we offer high-quality, affordable, accessible genomic testing for all. Our cutting-edge Naleya Genomics Lab, powered by BGI technology, provides efficient DNA-based screenings, including NIPT, newborn disease screening, lifestyle genomics test, and early cancer risk detection.

Vision

Becoming a leading and integrated provider of healthcare solutions based on omics.

Mission

Providing services that prioritize quality, competitive pricing, and ease of access across Indonesia.

Naleya Genomik Indonesia

Standards of Quality

PT Naleya Genomik Indonesia is committed to delivering service excellence and fostering continual improvement in compliance with applicable regulations and customer requirements, with a strong focus on:

Optimal Service
Providing optimal services to meet the needs of Indonesia’s diverse population.
Quality
Ensuring laboratory services are accurate, precise, and aligned with international standards, while fully adhering to regulations.
Innovation
Continuously advancing technology, enhancing human resource competencies, and refining systems to foster innovation.
Customer Satisfaction
Delivering wholehearted and professional services to achieve the highest level of customer satisfaction.

Naleya Genomik Indonesia

Who We Are

Vision

Mission

Naleya Genomik Indonesia

Standards of Quality

Quick Link

Connect with Us

Contact Info